Paid Clinical Trials in Mountain View, CA
As of August 2026, 36 paid clinical trials are recruiting in Mountain View, California. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Mountain View offers studies at sites including Palo Alto Medical Foundation-Camino Division for conditions such as Epiretinal Membrane, Neovascular Age-Related Macular Degeneration (nAMD), Stage III Pancreatic Cancer AJCC v8, Stage IV Pancreatic Cancer AJCC v8. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Mountain View
Trials by drug in Mountain View
Filter results
Newly added in Mountain View
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
32 clinical trials
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)
COMO: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
A Dose-masked Study of Intravitreal EYE103 in Participants With NVAMD or Macular Edema Following BRVO
Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
Surabgene Lomparvovec Administered in the Suprachoroidal Space in Adult Participants With Diabetic Retinopathy Without Center-Involved Diabetic Macular Edema
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
STRIVE Post-Market Registry Study
Generative AI Plan for Care Lab Study
In Vivo Cross-Modal Imaging of Skin
Evaluating the Effect Of Rifaximin on the Gut Microbiota and Metabolome in SIBO Using CapScan®
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT Trial
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Randomized Trial Comparing Immediate vs. Deferred Surgery for Symptomatic ERM
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
Follow-up Automatically vs. As-Needed Comparison (FAAN-C) Trial
Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma
Top Research Study Locations in Mountain View
Researchers run research studies in Mountain View, CA at 20 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Palo Alto Medical Foundation-Camino Division | Stage III Pancreatic Cancer AJCC v8, Stage IV Pancreatic Cancer AJCC v8, Advanced Esophageal Adenocarcinoma | 13 |
| Palo Alto Medical Foundation-Gynecologic Oncology | Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma, Advanced Gastroesophageal Junction Adenocarcinoma | 9 |
| El Camino Hospital | Early Breast Cancer, Mitral Valve Regurgitation | 2 |
| Northern California Retina Vitreous Associates | Dry Age Related Macular Degeneration, Epiretinal Membrane, IS/OS (Ellipsoid Zone) Disruption | 2 |
| Northern California Retina Vitreous Associates Medical Group Inc | Diabetic Retinopathy, DR, Neovascular Age-Related Macular Degeneration (nAMD) | 2 |
| Northern California Retina Vitreous Associates Medical Group, Inc. | Age-Related Macular Degeneration, Age-related Macular Degeneration (AMD), Choroidal Neovascularization | 2 |
| Silicon Valley Gastroenterology | Healthy Subjects, Small Intestinal Bacterial Overgrowth | 2 |
| El Camino Hospital Cancer Center | Breast Neoplasms, HR Low-Positive/HER2-Negative Breast Neoplasms, Triple Negative Breast Neoplasms | 1 |
| El Camino, Taft Center for Clinical Research | Emphysema | 1 |
| Enspectra Health | Skin | 1 |
| Google LLC | Primary Health Care | 1 |
| Mountain View, California | Branch Retinal Vein Occlusion (BRVO), Neovascular Age-Related Macular Degeneration (NVAMD) | 1 |
| NASA Ames Research Center | Alertness, Fatigue, Mood, and Performance, Calorie Restriction and Light Intervention | 1 |
| Northern California Retina Vitreous Associates - Mountain View | Neovascular Age-related Macular Degeneration | 1 |
| Northern California Retina Vitreous Associates | Diabetic Retinopathy | 1 |
| Northern California Retina Vitreous Associates Medical Group INC. | DME, Diabetic Macular Edema, Diabetic Macular Edema (DME) | 1 |
| Packard at El Camino Hospital | Gastroenteritis, Pneumonia, Soft Tissue Infections | 1 |
| Palo Alto Medical Foundation | Early Breast Cancer | 1 |
| Retina Vitreous Associates, Northern California Retina Vitreous Assoc Medical Group, Inc. | Epiretinal Membrane | 1 |
| USNC | Benign Prostatic Hyperplasia, Overactive Bladder, Prostate Cancer | 1 |
Active & Upcoming Studies in Mountain View (2026)
Recruiting trials in Mountain View grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (16 active studies)
- Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations · Phase 3 · SWOG Cancer Research Network
- Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT Trial · Phase 3 · NRG Oncology
Eye & vision (8 active studies)
- A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003) · Phase 2, Phase 3 · EyeBiotech Ltd.
- COMO: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME · Phase 3 · EyePoint Pharmaceuticals, Inc.
Common conditions studied in Mountain View
- Epiretinal Membrane (2 active studies)
- Neovascular Age-Related Macular Degeneration (nAMD) (2 active studies)
- Stage III Pancreatic Cancer AJCC v8 (2 active studies)
- Stage IV Pancreatic Cancer AJCC v8 (2 active studies)
- Advanced Esophageal Adenocarcinoma (1 active study)
- Advanced Gastric Adenocarcinoma (1 active study)
Leading research sponsors in Mountain View
- NRG Oncology
- AbbVie
- SWOG Cancer Research Network
- Envivo Bio Inc
- EyeBiotech Ltd.
Frequently asked questions
How many paid clinical trials are currently recruiting in Mountain View?
There are approximately 36 recruiting clinical trials in Mountain View, California listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Mountain View pay participants?
Most recruiting trials in Mountain View compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Mountain View?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Mountain View?
The most common conditions under active study in Mountain View include Epiretinal Membrane (2), Neovascular Age-Related Macular Degeneration (nAMD) (2), Stage III Pancreatic Cancer AJCC v8 (2), Stage IV Pancreatic Cancer AJCC v8 (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Mountain View?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Mountain View on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Mountain View?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Mountain View?
Recruiting research sites in Mountain View include Palo Alto Medical Foundation-Camino Division, Palo Alto Medical Foundation-Gynecologic Oncology, El Camino Hospital, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Mountain View right now?
The largest active categories in Mountain View are Cancer & tumors (16), Eye & vision (8). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.